These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 28029617)
21. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma. Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660 [TBL] [Abstract][Full Text] [Related]
23. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery. Zhang Y; Li J; Lang M; Tang X; Li L; Shen X J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493 [TBL] [Abstract][Full Text] [Related]
24. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Gao Z; Li Z; Yan J; Wang P Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710 [TBL] [Abstract][Full Text] [Related]
25. EpCAM aptamer activated 5-FU-loaded PLGA nanoparticles in CRC treatment; in vitro and in vivo study. Yavari B; Athari SS; Omidi Y; Jalali A; Najafi R J Drug Target; 2023 Mar; 31(3):296-309. PubMed ID: 36398476 [TBL] [Abstract][Full Text] [Related]
26. Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy. Khan S; Aamir MN; Madni A; Jan N; Khan A; Jabar A; Shah H; Rahim MA; Ali A Life Sci; 2021 Nov; 284():119909. PubMed ID: 34450169 [TBL] [Abstract][Full Text] [Related]
27. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer. Ortiz R; Prados J; Melguizo C; Arias JL; Ruiz MA; Alvarez PJ; Caba O; Luque R; Segura A; Aránega A Int J Nanomedicine; 2012; 7():95-107. PubMed ID: 22275826 [TBL] [Abstract][Full Text] [Related]
28. Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation. Shah M; Ullah N; Choi MH; Kim MO; Yoon SC Eur J Pharm Biopharm; 2012 Apr; 80(3):518-27. PubMed ID: 22178562 [TBL] [Abstract][Full Text] [Related]
29. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity. Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812 [TBL] [Abstract][Full Text] [Related]
30. Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines. Eatemadi A; Darabi M; Afraidooni L; Zarghami N; Daraee H; Eskandari L; Mellatyar H; Akbarzadeh A Artif Cells Nanomed Biotechnol; 2016 May; 44(3):1008-17. PubMed ID: 25707442 [TBL] [Abstract][Full Text] [Related]
31. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization. Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107 [TBL] [Abstract][Full Text] [Related]
32. Star-shaped polycaprolactone-polyethyleneglycol copolymer micelle-like nanoparticles for picropodophyllin delivery. Zhao J; Wang Y; Luan L J Biomed Nanotechnol; 2014 Aug; 10(8):1627-34. PubMed ID: 25016662 [TBL] [Abstract][Full Text] [Related]
33. Preparation, evaluation, and Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system. Amjadi I; Rabiee M; Hosseini MS; Mozafari M Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852 [TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery. Yu X; Hou J; Shi Y; Su C; Zhao L Int J Nanomedicine; 2016; 11():6035-6046. PubMed ID: 27881917 [TBL] [Abstract][Full Text] [Related]
36. Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release. Ibrahim MM; Abd-Elgawad AE; Soliman OA; Jablonski MM J Pharm Sci; 2013 Mar; 102(3):1036-53. PubMed ID: 23293035 [TBL] [Abstract][Full Text] [Related]
37. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy. Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the Uptake Efficiency and Cytotoxicity of Tetrandrine-Loaded Poly(N-vinylpyrrolidone)-Block-Poly(ε-caprolactone) (PVP-b-PCL) Nanoparticles in the A549 Lung Adenocarcinoma Cell Line. Xu H; Li X; Kong H; Zeng X; Jin Y; Qi Y; Wang H; Xie W J Biomed Nanotechnol; 2016 Aug; 12(8):1699-707. PubMed ID: 29342348 [TBL] [Abstract][Full Text] [Related]
39. Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment. Sanna V; Siddiqui IA; Sechi M; Mukhtar H Mol Pharm; 2013 Oct; 10(10):3871-81. PubMed ID: 23968375 [TBL] [Abstract][Full Text] [Related]
40. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo. Mishra BJ; Kaul A; Trivedi P Drug Deliv; 2015 Feb; 22(2):214-22. PubMed ID: 24524408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]